2,3-Dihydrobenzofuran derivatives having various sulfamoyl groups at the 5-position were synthesized and tested for oral diuretic and saluretic activities in rats and mice. Intraperitoneal uricosuric activity was also tested by a clearance method using oxonate-treated rats. Structureactivity relationships are presented. The 6,7-dichloro-5-N,N-disubstituted sulfamoy1-2,3-dihydrobenzofuran-2-carboxylic acids (9ab, ac, 13a and b) having lower alkyl substituents showed the most potent diuretic and saluretic activities among the compounds synthesized. Hyperuricosuric activity was observed in 6,7-dichloro-2,3-dihydrobenzofuran-2-carboxylic acids and 2-hydroxymethy1-6,7-dichloro-2,3-dihydrobenzofurans having a 5-sulfamoyl group, with relatively small substituents (9aa-ac, af, ak, al, an, ao and 16a-c). The saluretic activity of 9ab showed a high-ceiling profile. Examination of the enantiomers of 9ab revealed that the (-)-enantiomer is responsible for most of the diuretic and saluretic activities, while the (+)-enantiomer is responsible for most of the uricosuric activity.
2,3-Dihydrobenzofuran derivatives having various sulfamoyl groups at the 5-position were synthesized and tested for oral diuretic and saluretic activities in rats and mice. Intraperitoneal uricosuric activity was also tested by a clearance method using oxonate-treated rats. Structureactivity relationships are presented. The 6,7-dichloro-5-N,N-disubstituted sulfamoy1-2,3-dihydrobenzofuran-2-carboxylic acids (9ab, ac, 13a and b) having lower alkyl substituents showed the most potent diuretic and saluretic activities among the compounds synthesized. Hyperuricosuric activity was observed in 6,7-dichloro-2,3-dihydrobenzofuran-2-carboxylic acids and 2-hydroxymethy1-6,7-dichloro-2,3-dihydrobenzofurans having a 5-sulfamoyl group, with relatively small substituents (9aa-ac, af, ak, al, an, ao and 16a-c). The saluretic activity of 9ab showed a high-ceiling profile. Examination of the enantiomers of 9ab revealed that the (-)-enantiomer is responsible for most of the diuretic and saluretic activities, while the (+)-enantiomer is responsible for most of the uricosuric activity.
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2,3-dihydrobenzofuran-5-sulfonamide; structure-activity relationship; S-8666 Diuretics are widely used as the agents of choice in hypertension therapy. temporary diuresis, occasionally fail to decrease blood pressure because of their short action time. Recently, however, they have been used in sustained-release preparations in order to avoid the side effects caused by thiazides. One large family of modern diuretics, first recognized with the discovery of ethacrynic acid, is that of aryloxyacetates.11 Recently, many new compounds having interesting pharmacological actions, including uricosuric and diuretic activities have been reported from this family, e.g., tienilic acid (1),1) indacrinone (2),1,2) 3,1,3) HP-522 (4),4) and 55) (Chart 1).
We tried to create a new type of uricosuric diuretic which would display temporary diuretic action and inhibit reabsorption of uric acid by renal tubules. The structure of 5-acyl-2,3-dihydrobenzofuran-2-carboxylic acid, found in compounds 3-5, seemed to be a developed form of 4-acylphenoxyacetic acid. A promising substituent was considered to be the sulfamoyl group, which is found in thiazide diuretics and probenecid, a uricosuric drug. We therefore synthesized some dihydrobenzofuran derivatives with 5-sulfamoyl substituents and found that they display both actions.
Chemistry
The compounds prepared for this study are shown in Table I and their syntheses are outlined in Charts 2 and 3. The starting materials (7a and 14,3) 7b, c and e,6) d71 are described in the literature.
5-Sulfamoyl-2,3-dihydrobenzofuran-2-carboxylic acids (9aa-az and 9ba-bd) were obtained by chlorosulfonation of the corresponding esters (7) with chlorosulfonic acid and thionyl chloride followed by aminolysis and hydrolysis. The esters 10a and b were prepared by alkylation of the potassium salt of 9ab with phthalidyl bromide or iodomethyl pivalate. The esters 10c and d were prepared by the reaction of diphenylmethyl glycolate with acid chlorides Chart 2 of 9ab and 9ac followed by hydrolysis with trifluoroacetic acid. The 2-carboxamides (11a-c) were obtained by aminolysis of the ethyl esters (8ab). The urethane (12) was prepared by ethoxycarbonylation of 9an benzhydryl ester with ethyl chloroformate and sodium hydride followed by hydrolysis with trifluoroacetic acid and anisole. The 5-(N-ethyl-N-methyl)-and 5-(N-methyl-N-propyl)sulfamoyl derivatives (13a and b) were prepared by alkylation of 8an with the corresponding alkyl halides in the presence of sodium hydride followed by alkaline hydrolysis (Chart 2).
The 2-hydroxymethyl-2,3-dihydrobenzofuran-5-sulfonamide derivatives (16) were prepared by sulfamoylation of the acetate of 14 followed by alkaline hydrolysis through a procedure similar to that described for the preparation of 9 (Chart 3). 2-Chloromethyl derivatives (17a and b) were obtained by chlorination of 16a and b, and 2-ethoxymethyl derivatives (18a and b) were synthesized by sulfamoylation of the ethoxy derivative of 14 or by direct ethylation of 16b, respectively. Intermediates to the above compounds are described in the experimental section.
Optical resolution of 9ab was carried out as outlined in Chart 4. The diastereoisomeric amides (19) were obtained by the reaction of the acid chloride of 9ab with L-proline tert-butyl ester in the presence of triethylamine and 4-N,N-dimethylaminopyridine in dry benzene under ice-cooling. One isomer (19a) was readily crystallized from the mixture and the resultant mother liquor was separated by silica gel column chromatography. The separated diastereoisomers (19a and b) were hydrolyzed in aqueous sulfuric acid-dioxane under reflux to give the optically active enantiomers [ (-)-and ( + )-9ab], which showed the same melting points and optical rotations (except for the sign). chlormethiazide. The time course of natriuretic activity in rats administered 9ab orally is shown in Fig. 4 . Compound 9ab showed temporary natriuresis. These data suggest that the main site of action of 9ab inducing diuresis may be in the loop of Henle.
Optical isomers of 9ab, resolved as shown in Chart 4, were tested in rats and mice in comparison with the racemate. The (-)-enantiomer possesses most of the saluretic activity A method has been developed8) to test uricosuric activity using rats treated with potassium oxonate which is known to be a uricase inhibitor. The test compounds were administered intraperitoneally and the uricosuric activity was evaluated in terms of the increase in fractional excretion of uric acid (FEua) and urine-excreted amounts of uric acid (UuaV) values. The results are listed in Table III Among 6,7-dichloro-2,3-dihydrobenzofuran derivatives having either a 2-carboxyl or a 2-hydroxymethyl group, marked increases of both FEua and UuaV were observed in variants having unsubstituted and mono-or disubstituted sulfonamides (9aa-ac, af, ak, al, an, ao, and 16a-c) in which the substituents were lower alkyl groups. Accordingly, these compounds are expected to show a hyperuricosuric character in higher animals, including man.
The resolved enantiomers of 9ab were tested for uricosuric activity. The ( + ) enantiomer had this activity, while the (-) enantiomer showed an increase in UuaV with a slight decrease of FEua.
Indacrinone (2) has been reported to show urate-retaining activity as a result of potent and long-lasting diuresis in clinical trials.91 The diuretic potency of 9ab seems to be intermediate between those of 2-5 and tienilic acid (1).1,3,5) Thus, it should show both uricosuric and moderate diuretic actions, which would allow its use in clinical antihypertensive therapy. We therefore selected 9ab for clinical evaluation, and further investigation is in progress.
Experimental
Melting points were determined on a Yanagimoto hot plate micro melting point apparatus and are uncorrected. The proton nuclear magnetic resonance (11-1-NMR) spectra were taken on a Varian EM-390 spectrometer with tetramethylsilane (TMS) as an internal standard. Signal multiplicities are represented by s (singlet), d (doublet), t (triplet), q (quartet), br (broad), m (mu,ltiplet). Chemical shifts are expressed in .5 values and the coupling constants in Hz. Abbreviations are as follows: Ph, phenyl; arom. H, aromatic proton(s). For column chromatography, Silica gel 60 (E. Merck, 0.063-0.200 mm) was used. Compounds 8aa, Sac-az and 8ba-bd were obtained in a similar manner (Table IV) . 1H-NMR spectral data are given in Table V. 6,7-Dichloro-5-N,N-dimethylsulfamoy1-2,3-dihydrobenzofuran-2-carboxylic Acid (9ab) A 15% aqueous potassium carbonate solution (14 ml) was added to a solution of 8ab (1.0 g, 0.0029 mol) in tetrahydrofuran (9 ml), and the mixture was stirred for 72 h at room temperature. Concentration of the reaction mixture in vacuo left a residue, which was acidified to pH 5, then extracted with ethyl acetate. The organic layer was dried and evaporated in vacuo, leaving an oil, which, when treated with ether, gave 9ab (0.868 g, 94%). Compounds 9aa, 9ac-az and 9ba-bd were obtained in a similar manner. 11-I-NMR spectral data for 9aa-az and 9ba-bd are listed in Table VI Pivaloyloxymethyl 6,7-Dichloro-5-N,N-dimethylsulfamoy1-2,3-dihydrobenzofutan-2-carboxylate (10b) Pivaloyloxymethyl iodide (1.5 g, 2.1 x 0.0029 mol) was added dropwise to a solution of the potassium salt of 9ab (1.0 g, 0.0029 mol) in acetonitrile (10 ml) at 20 °C, and the mixture was refluxed for 2.5 h. The insoluble matter was removed by filtration, and the reaction solution was extracted with ethyl acetate. The organic layer was washed with water, dried and evaporated in vacua, giving a crystalline residue. Chromatography of this residue using dichloromethane as the eluant gave 10b (0.911 g, 69%). 1H-NMR spectral data are given in Table VI. 6,7-Dichloro-5-N,N-dimethylsulfamoy1-2,3-dihydrobenzofuran-2-yl-carbonyloxyacetic Acid (10c) The acid chloride of 9ab, which was formed by treatment of 9ab (1.0 g, 0.0029 mol) with thionyl chloride (1.5 ml) in benzene Trifluoroacetic acid (1 ml) was added to a stirred suspension of this compound (0.85 g) in anisole (1 ml) under icecooling. After being stirred for 1 h at room temperature, the reaction mixture was evaporated in vacua. The residue was recrystallized from hexane-ether, giving 10c (0.599 g, 100%).
Compound 10d was obtained in a similar manner; yield 70%. 1H-NMR spectral data for 10a-d are given in Table VI. 6,7-Dichloro-5-N,N-dimethylsulfamoy1-2,3-dihydrobenzofuran-2-carboxamide (11a) A solution of 8ab (0.500 g, 0.0016 mol) in 20% ethanolic ammonia (50 ml) was stirred for 17h at room temperature. Evaporation of the reaction mixture in vacua gave a crystalline residue, which was washed with ether, giving lla (0.448 g, 97%).
Compounds llb and 11c were obtained in a similar manner. Compound 11b, yield 98%. Compound 11c, yield 70%. 11-1-NMR spectral data for lla-c are listed in Table VI. 6,7-Dichloro-5-(N-ethoxycarbonyl-N-methylsulfamoy1)-2,3-dihydrobenzofuran-2-carboxylic Acid (12)-Diphenyl diazomethane (1.3 g, 0.0067 mol) was gently added to a solution of 9an (1.5 g, 0.0046 mol) in dichloromethane (20 ml) under ice-cooling. The mixture was stirred for 2 h at room temperature, then the remaining reagent was decomposed by adding 10% hydrochloric acid. The mixture was extracted with dichloromethane (60 ml), then the organic layer was washed with water, dried and evaporated in vacua. The residue was chromatographed using dichloromethane as the eluant to give benzhydryl 6,7-dichloro-5-N-methylsulfamoy1-2,3-dihydrobenzofuran-2-carboxylate (2.06 g, 91%), mp 132-133 °C (hexane-ether). Sodium hydride (50% suspension in oil, 0.180 g, 0.0038 mol) was gently added to a solution of the ester (1.655 g, 0.0034 mol) in DMF (20 ml) at 4 °C, and the mixture was stirred for 1 h at room temperature. Next, ethyl chloroformate (0.41 g, 0.0038 mol) was added, and the reaction was allowed to continue for 1 h. The reaction mixture was then poured into water and extracted with ether (300 ml). The organic layer was dried and evaporated in vacua, giving an oily residue. Chromatography of this residue using dichloromethane as the eluant gave benzhydryl 6,7-dichloro-5-(V-ethoxycarbonyl-N-methylsulfamoy1)-2,3-dihydrobenzofuran-2-carboxylate (1. compound obtained above in anisole (3 ml) under ice-cooling, and the mixture was stirred at room temperature for 1 h. Evaporation of the reaction mixture in vacuo gave a residue, which, when treated with hexane, gave 12 (0.942 g, 100%). Recrystallization from hexane-ether-acetone gave colorless crystals, mp 199-201 °C, 1H-NMR spectral data of which are given in Table VI . 6,7-Dichloro-5-(N-ethyl-N-methylsulfamoyl)-2,3-dihydrobenzofuran-2-carboxylic Acid (13a) Sodium hydride 50%; (0.150 g, 0.0031 mol) was added to a solution of 8an (1.0 g, 0.0031 mol) in anhydrous DMF (10 ml) and the mixture was stirred for 30 min. After addition of ethyl bromide (0.40 g, 0.0036 mol) under ice-cooling, the mixture was stirred for 30 min under ice-cooling and then for another 30 min at room temperature. Next, 10% hydrochloric acid (1.0 ml) and water (10 ml) were added to the reaction mixture, which was then extracted with ether (80 ml). The ether layer was dried and evaporated in vacuo, giving a residue. A solution of the residue in ether was combined with an ethereal solution of diazomethane and allowed to react for 30 min. Evaporation of the reaction mixture in vacuo gave a residue, which, when chromatographed using dichloromethane-ether as the eluant, gave ethyl 6,7-dichloro- (2 ml), and the mixture was stirred for 30 min. Evaporation of the reaction mixture in vacuo gave a residue, which was acidified with 10% hydrochloric acid and extracted with ethyl acetate (50 ml). The ethyl acetate layer was dried and evaporated, giving a viscous residue. The residue was dissolved in acetonitrile (10 ml), then combined with 1 N sodium hydroxide (1.6 ml), and the mixture was stirred for 30 min under ice-cooling. The precipitated crystals were collected by filtration, then recrystallized from aqueous ethanol, giving 13a Table VI. 6,7-Dichloro-5-N,N-dimethylsulfamoy1-2,3-dihydrobenzofuran-2-ylmethyl Acetate (15b) Acetyl chloride (5.37 g, 1.5 x 0.0457 mol) was added dropwise to a solution of 14 (10.0 g, 0.0457 mol) and 4-N,N-dimethylaminopyridine (11.13 g, 2 x 0.0457 mol) in dichloromethane (100 ml) under ice-cooling, and the reaction mixture was stirred for 1 h. Next, dichloromethane (100 ml) was added, and the organic layer was washed several times with water, then dried and evaporated. The residue was chromatographed and eluted with dichloromethane, giving oily 6,7-dichloro-2,3-dihydrobenzofuran-2-ylmethyl acetate (11.04 g, 93%) . 11-1-NMR (in CDC13) 6: 2.06 (3H, s, COCH3 30 (1H, m, 0-CH), 6.93 (2H, s, arom. H) . Chlorosulfonic acid (1.25 ml) was added to a solution of this oily acetate (1.0 g, 0.0038 mol) in thionyl chloride (2 ml) under ice-cooling, and the mixture was stirred at room temperature for 2 h. The reaction mixture was poured into ice water and extracted with ether. The ethereal layer was washed with water, then dried and evaporated in vacuo. A 30% ethanolic solution of dimethylamine (1.8 ml, 3 x 0.0038 mol) was added dropwise to a solution of this oily chlorosulfonate in dichloromethane (10 ml) at -30 °C, and the mixture was stirred for 2 h. Next, dichloromethane was added, then the reaction mixture was washed with 10% hydrochloric acid. The organic layer was dried, evaporated in vacuo and treated with ether, giving 15b (1.24 g, 88%) .
Compounds 15a and 15c-g were obtained in a similar manner (Table IV) . 11-I-NMR spectral data for 15a-g are given in Table V. 6,7-Dichloro-2-hydroxymethyl-N,N-dimethyl-2,3-dihydrobenzofuran-5-sulfonamide (16b)--A solution of 15b (2.94 g, 0.0080 mol) in tetrahydrofuran (15 ml) was stirred with 5% sodium hydroxide (7.5 ml) at room temperature for 2 h. The reaction mixture became transparent. After removal of tetrahydrofuran by evaporation in vacuo, the reaction mixture was acidified and extracted with ethyl acetate. The organic layer was washed with water, dried and evaporated in vacuo. The residue was treated with ether-ethyl acetate, giving 16b (2.15 g, 89%).
Compounds 16a and 16c-g were obtained in a similar manner. 1H-NMR spectral data for 16a-g are given in Table  VI. 2-Chloromethy1-6,7-dichloro-N,N-dimethy1-2,3-dihydrobenzofuran-5-sulfonamide (17b) Thionyl chloride (1 ml) was added dropwise to a solution of 16b (1.0 g, 0.0031 mol) in pyridine (10 ml) at 4 °C, and the mixture was stirred at room temperature for 21 h. Next, 10% hydrochloric acid was added, and the mixture was extracted with ethyl acetate (200 ml). The organic layer was washed with 10% hydrochloric acid and then water, dried and evaporated in vacuo. Chromatography of the residue using dichloromethane as the eluant gave 17b (0.663 g, 63%). Compound 17a was obtained in a similar manner. Yield 66%. 1H-NMR spectral data for 17a, b are given in Table VI. 6,7-Dichloro-2-ethoxymethyl-2,3-dihydrobenzofuran-5-sulfonamide (18a) Sodium hydride 50%; (0.790 g, 0.0165 mol) was added to a solution of 14 (2.88 g, 0.0132 mol) in DMF (22 ml), and the mixture was stirred at room temperature for 30 min. Next, ethyl bromide (1.73 g, 0.0159 mol) was added, and the mixture was allowed to react at room temperature for 17 h. After decomposition of sodium hydride by addition of water, the reactant was extracted with ether. The ether layer was washed with water, dried and evaporated in vacuo, giving a residue, which, when chromatographed with dichloromethane, gave oily 6,7-dichloro-2-ethoxymethyl-2,3-dihydrobenzofuran (2.0 g, 62%).
Chlorosulfonic acid (3.0 g, 0.0258 mol) was added dropwise to a solution of this compound (2.0 g, 0.0081 mol) in thionyl chloride (5 ml) under ice-cooling. The reaction mixture was stirred at room temperature for 2 h, poured into ice water, and then extracted with ethyl acetate. The organic layer was washed with water, dried and evaporated in vacuo, giving an oil, which was then dissolved in dichloromethane (30 ml). After introduction of gaseous ammonia at -30--20 °C , the mixture was allowed to stand overnight at room temperature. The reaction mixture was evaporated in vacuo and the residue was dissolved in ethyl acetate. The solution was washed with water, dried and evaporated in vacuo, leaving an oily residue, which, when chromatographed with dichloromethane-acetone (20 : 1), gave 18a (0.900 g, 24%).
6,7-Dichloro-N,N-dimethy1-2-ethoxymethy1-2,3-dihydrobenzofuran-5-sulfonamide (18b) Sodium hydride 50%; (0.200 g, 0.0031 mol) was added to a solution of 16b (1.0 g, 0.0031 mol) in DMF (8 ml), and the mixture was stirred at room temperature for 30 min. After addition of ethyl bromide (0.450 g, 1.3 x 0.0031 mol), the reaction mixture was stirred at room temperature for 24 h and then combined with water and ether. The organic layer was washed twice with water, dried and evaporated in vacuo, leaving an oily residue, which, when chromatographed with dichloromethane-acetone (20: 1), gave 18b (0.464g, 43%). 1H-NMR spectral data for 18a, b are given in Table VI .
Resolution of the Optical Isomers of 9ab---Thionyl chloride (2.5 ml) was added to a stirred solution of 9ab (1.50 g, 0.0044 mol) in absolute benzene (10 ml), and the solution was refluxed for 1 h, then evaporated in vacuo. The resulting oily acid chloride was dissolved in benzene (5 ml), and a solution of L-proline tert-butyl ester (0.90 g, 0.0053 mol), triethylamine (0.88 g, 0.0088 mol) and 4-N,N-dimethylaminopyridine (0.053 g, 0.0004 mol) in benzene (10 ml) was added dropwise with stirring at 4 °C. The mixture was allowed to react for 1 h, then evaporated in vacuo. The residue was dissolved in ethyl acetate (150 ml), and the solution was washed successively with 10% hydrochloric acid and water, dried and evaporated in vacuo. Treatment of the oily residue with ether gave colorless crystals of a diastereomer, 19a (0.924 g, 44%). The mother liquor was chromatographed with a silica gel Lobar column (E. Merck, size B), which was eluted with dichloromethane-acetone (20 : 1). After separation of small amounts of 19a, collection of the subsequent fractions gave oily 19b (0.89 g, 42%), which crystallized in a refrigerator at -20 °C. A solution of 19a (11.8 g, 0.0239 mol) in water (10 ml), concentrated sulfuric acid (25 g) and dioxane (225 ml) was heated at 90 °C with stirring for 17 h. After addition of water (200 ml), the solution was extracted with ethyl acetate (800 ml), then the organic layer was washed with water three times, dried and evaporated in vacuo. The residue was dissolved in a solution of sodium hydroxide (95%, 1.1 g, 0.0261 mol) and water (20 ml), and then acetonitrile (40 ml) was added. The precipitated crystalline material was collected by filtration and suspended in 10% hydrochloric acid. The suspension was extracted with ethyl acetate and the organic layer was washed with water, dried and evaporated in vacuo. Treatment of the residue with hexane-ethyl acetate gave (-)-9ab (7. Diuretic Effect on Rats Male Sprague-Dawley rats, weighing about 250 g, at 8 weeks of age, were used in this test. A few lumps of sugar in place of ordinary diet were given on the morning of the day before the test day and 20 ml/kg of 5% glucose solution was given orally at approximately 4 p.m. On the morning of the test day, a suspension or solution of the test compound in 2% gum arabic was orally administered to each rat at a dose of 20 ml/kg. The control group received only 2% gum arabic orally at 20 ml/kg. Immediately after the administration, the test animals were put in plastic cages for the metabolic tests and urine samples were collected for 5 h. The cumulative urine volume, urinary sodium, and urinary potassium were quantitated.
Diuretic Effect on Mice Female ddY mice, weighing about 20 g, were used for the test. The mice were fasted overnight, but were allowed free access to water. On the morning of the test day, a suspension or solution of the test compound in 2% gum arabic was orally administered to each mouse at 30 ml/kg. The control mice received only the vehicle. Immediately after the administration, five mice of the treated group were put together in a plastic cage for the metabolic tests and urine was collected for 4 h. The cumulative urine volume, urinary sodium, and urinary potassium were quantitated.
Uricosuric Effect on Rats Nine-week-old male rats were employed for the test. Potassium oxonate was intraperitoneally administered to the animals at a dose of 250 mg/kg to measure uric acid clearance and inulin clearance. Within 2 h after the administration of the potassium oxonate, cannulae were placed in the right femoral artery, left femoral vein, and urinary bladder of each animal under pentobarbital anesthesia for blood collection, drug infusion, and urine collection, respectively. At 2 h after the first administration, potassium oxonate was administered again at the same dosage and then 60% urethane (2 ml/kg) and 15% inulin (4 ml/kg) were subcutaneously injected. A mixture of 4% mannitol-1.5% inulin-0.9% saline was infused at the flow rate of 0.1 ml/min into each animal on a plate kept at 30 °C. The animal was allowed 40 min to reach an equilibrium state, then arterial blood (0.2 ml each) samples were collected six times at 20-min intervals, and five 20-min urine samples were collected. Immediately after the collection of each blood sample, the serum was separated. The serum and urine samples were stored in a refrigerator.
Immediately after collection of the first urine sample, a test compound suspended in 1% gum arabic was intraperitoneally administered at 2 ml/kg. Uric acid levels in the serum and the urine were quantitated by the method of Yonetani et al.') Inulin was measured essentially by the method of Vurek and Pegram.11 To analyze uric acid, 0.1 ml of a diluted solution of deproteinized serum or urine was admixed with a 1% dimedone-phosphoric acid solution and the resulting mixture was heated for 5 min. The mixture was then cooled in iced water and combined with 2.0 ml of acetic acid. The fluorescence was measured at 410 nm with excitation at 360 nm.
